Home » Authors » Kim Coghill

Articles by Kim Coghill

FDA Panel Discusses Endpoints For Approval Of Gout Products

June 3, 2004

FDA Panel Discusses Endpoints For Approval Of Gout Products

June 3, 2004

Serono Starts Phase III Trial Of Serostim In HARS Patients

June 2, 2004

SuperGen Submits First Part Of Rolling NDA For Dacogen

June 2, 2004

SuperGen Submits First Part Of Rolling NDA For Dacogen

June 2, 2004

Serono Starts Phase III Trial Of Serostim In HARS Patients

June 2, 2004

Avigen Stops Coagulin-B Phase I, Plans Drug's Future With Bayer

June 1, 2004

Avigen Stops Coagulin-B Phase I, Plans Drug's Future With Bayer

June 1, 2004

Syrrx Receives Milestone From Biogen Idec In Target Agreement

May 28, 2004

With MyVax In Phase III, Genitope Raising $51.8M In Public Offering

May 28, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 25, 2025.
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 24, 2025
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...